Skip to main content

Advertisement

SpringerLink
Log in

Endothelial progenitor cells in breast cancer patients

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Development of new capillary blood vessels is essential for the growth of cancer. Two distinct processes, vasculogenesis and angiogenesis implement the formation of the new vascular network. Recently, it was demonstrated that vasculogenesis creates the primary network of vascular endothelial cells that will become major blood vessels in malignant tumors by the recruitment of CD34+/vascular endothelial growth factor receptor 2 (FLK-1)+ endothelial progenitor cells (EPCs) to sites of the new vessel formation with subsequent differentiation into mature endothelial cell. Therefore the aim of this study was a) to quantitate EPCs in breast cancer patients and b) to evaluate if the release of EPCs into the circulation is mainly regulated by the tumor himself.

Experimental design

CD34+FLK-1+ EPCs were measured in the peripheral circulation of patients with breast cancer (n = 47) before and after therapy. Furthermore the potential of EPCs to differentiate into endothelial cells was investigated by late-outgrowth experiments and the metabolic uptake of dil-acetylated-LDL and immunoreactivity against von Willebrand factor.

Results

In breast cancer patients the amount of CD34+FLK-1+ EPCs (percent of peripheral blood mononuclear cells) is significantly increased in women with breast cancer. Tumors larger than 2 cm showed significantly higher values of CD34+FLK-1+ EPCs. After excision of the tumor the amount of CD34+FLK-1+ EPCs rapidly declines.

Conclusions

Our findings lead to the tumor, as source of angiogenic chemokines, is most important for recruiting CD34+FLK-1+ EPCs during breast cancer development. Therefore circulating endothelial progenitor cells may work as a new diagnostic tool in the screening and diagnosis of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Goldmann E (1907) The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 2:1236–1240

    Article  Google Scholar 

  2. Ide A, Baker NH, Warren SL (1939) Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am J Radiol 42:891–899

    Google Scholar 

  3. Algire GH, Chalkley HW (1945) Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst USA 6:73–85

    Google Scholar 

  4. Folkman J (2000) In: Holland JF et al (eds) Cancer medicine. Decker, Ontario, Canada, pp 132–152

    Google Scholar 

  5. Asahara T, Masuda H, Takahashi T et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularisation. Circ Res 85:221–228

    PubMed  CAS  Google Scholar 

  6. Gehling UM, Ergün S, Schumacher U et al (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95:3106–3112

    PubMed  CAS  Google Scholar 

  7. Lyden D, Hattori K, Dias S et al (2001) Impaired recruitment of bone-marrow-derived endothelial and haematopoetic precursor cells blocks tumor angiogenesis and growth. Nature Med 7:1194–1201

    Article  PubMed  CAS  Google Scholar 

  8. Reyes M, Dudek A, Jahagirgar B et al (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337–346

    Article  PubMed  CAS  Google Scholar 

  9. Asahara T, Takahashi T, Masuda H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964–3972

    Article  PubMed  CAS  Google Scholar 

  10. Shi Q, Rafii S, Wu MHD et al (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362–367

    PubMed  CAS  Google Scholar 

  11. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967

    Article  PubMed  CAS  Google Scholar 

  12. Lin Y, Weisdorf D, Solovey A, et al (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71–77

    Article  PubMed  CAS  Google Scholar 

  13. Gill M, Dias S, Hattori K et al (2001) Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+ AC133+ Endothelial Precursor Cells. Circ Res 88:167–174

    PubMed  CAS  Google Scholar 

  14. Peichev M, Naiyer A, Pereira D et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952–958

    PubMed  CAS  Google Scholar 

  15. Quirici N, Soligo D, Caneva L et al (2001) Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol 115:186–194

    Article  PubMed  CAS  Google Scholar 

  16. Hristov M, Erl W, Weber P (2003) Endothelial progenitor cells. Mobilization differentiation, and homing. Arterioscler Thromb Vasc Biol 23:1–6

    Article  CAS  Google Scholar 

  17. Rafii S (2000) Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105:17–19

    PubMed  CAS  Google Scholar 

  18. Lyden D, Young A, Zagzag D et al (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401:670–677

    Article  PubMed  CAS  Google Scholar 

  19. Carmeliet P, Moons L, Luttun A et al (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575–583

    Article  PubMed  CAS  Google Scholar 

  20. Rafii S, Lyden D, Benezra R et al (2002) Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nature Cancer Rev 2:826–835

    Article  CAS  Google Scholar 

  21. Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biololy 2:737–744

    Article  CAS  Google Scholar 

  22. Heissig B, Hattori K, Dias S et al (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9mediated release of Kit-ligand. Cell 109:625–637

    Article  PubMed  CAS  Google Scholar 

  23. Bertolini F, Paul S, Mancuso P et al (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63:4342–4346

    PubMed  CAS  Google Scholar 

  24. Kraft A, Weindel K, Ochs A et al (1999) Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85:178–187

    Article  PubMed  CAS  Google Scholar 

  25. Yamamoto Y, Toi M, Kondo S et al (1996) Concentrations of vascular endothelial growth factor in sera of normal controls and cancer patients. Clin Cancer Res 2:821–826

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

None of the authors received financial support or a grant for this study

Author information

Authors and Affiliations

  1. Department of Gynecology, Breast Unit, Charite, Universitätsmedizin Berlin, Campus Mitte, Chariteplatz 1, 10117, Berlin, Germany

    Christiane Richter-Ehrenstein & Achim Schneider

  2. Krankenhaus Görlitz, Gorlitz, Germany

    Jörn Rentzsch

  3. Bertoldstrasse 31, 78050, Villingen-Schwenningen, Germany

    Sanyukta Runkel

  4. Department of Pharmacology and Embryonaltoxicology, Universitätsmedizin Berlin, Garystr. 5, 14195, Berlin, Germany

    Gilbert Schönfelder

Authors
  1. Christiane Richter-Ehrenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jörn Rentzsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sanyukta Runkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Achim Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gilbert Schönfelder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christiane Richter-Ehrenstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richter-Ehrenstein, C., Rentzsch, J., Runkel, S. et al. Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Treat 106, 343–349 (2007). https://doi.org/10.1007/s10549-007-9505-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9505-z

Keywords

Search

Navigation